Combining academic research and industry is a way to ensure that research results become the best possible outcome for patients, for example through novel therapies. This is one of the intentions with the close collaboration between WCMTM and AstraZeneca.
AstraZeneca is a scientifically driven major pharmaceutical company, and one of the world leaders in the treatment of heart and respiratory diseases, and cancer. The research team in Sweden consists of talented and credible scientist, with significant international reputation – creating a perfect match for the promising, young researchers recruited to WCMTM. Together we explore collaborations and find synergies in our research fields for the benefit of patients.
Joint Post doc Program
Within the AstraZeneca and WCMTM framework, a joint post doc program has been initiated with several projects being conducted or have been finished. Below you can find a summary of our ongoing projects.